- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Velcade/Dexamethasone/cyclophosphamide
Total 7238 results
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
European Myeloma NetworkEMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Greece, Italy
-
Spectrum Health HospitalsMillennium Pharmaceuticals, Inc.CompletedHematological MalignancyUnited States
-
Centocor, Inc.WithdrawnMultiple MyelomaCanada, United States, Belgium, Poland, Bulgaria, Turkey, Ukraine, Australia, Korea, Republic of, New Zealand, Czech Republic, United Kingdom, Netherlands, India
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Laryngeal Cancer | Oral Cancer | Carcinoma, Squamous | Pharyngeal CancerUnited States
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Intergroupe Francophone du MyelomeUnknown
-
Children's Hospital Medical Center, CincinnatiBill and Melinda Gates Foundation; Syngene InternationalCompleted
-
University of LeedsMerck Sharp & Dohme LLC; Myeloma UKCompletedMultiple MyelomaUnited Kingdom
-
Seoul National University Bundang HospitalCompletedEvaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or BetamethasoneBack Pain | Neck PainKorea, Republic of
-
Ahmadu Bello University Teaching HospitalCompletedNeonatal Respiratory Distress SyndromeNigeria
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Intergroupe Francophone du MyelomeCompleted
-
University of OklahomaStony Brook UniversityCompletedIntraventricular Hemorrhage | Respiratory Distress Syndrome | Neonatal MortalityUnited States
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
PETHEMA FoundationCompleted
-
SanofiCompleted
-
University of ArkansasMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, Poland, Ukraine, Germany, Spain, Turkey, Korea, Republic of, Brazil, Russian Federation, Netherlands, Hungary, Sweden, Czechia, Mexico
-
Mayo ClinicCompletedPrimary Systemic AmyloidosisUnited States
-
PETHEMA FoundationCompleted
-
University of UlmCentre Hospitalier de Lens (Co-Sponsor)CompletedWaldenström's MacroglobulinemiaGermany
-
The Rogosin InstituteWeill Medical College of Cornell UniversityCompleted
-
Grupo de Estudos Multicentricos em Onco-HematologiaCompletedMultiple Myeloma | Effects of Chemotherapy
-
La Jolla Pharmaceutical CompanyTerminatedMultiple MyelomaUnited States
-
Oncology Specialists, S.C.Millennium Pharmaceuticals, Inc.TerminatedLymphoma, B-Cell | Lymphoma, Non-HodgkinUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma
-
Tel-Aviv Sourasky Medical CenterUnknownScars | Keloid | Hypertrophic Scar | Scarring
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
Yongping ZhaiUnknownMultiple MyelomaChina
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCCompleted
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
University Health Network, TorontoAstellas Pharma Inc; Multiple Myeloma Research ConsortiumTerminatedMultiple MyelomaUnited States, Canada
-
Janssen-Cilag G.m.b.HCompleted
-
University of PittsburghNovartisWithdrawnMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Nantes University HospitalCompleted
-
European Myeloma NetworkJanssen PharmaceuticaActive, not recruitingLight Chain (AL) Amyloidosis, Stage 3BNetherlands, Greece, France, Italy
-
Columbia UniversityUnknownMesotheliomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); SanofiRecruitingAL AmyloidosisUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedA Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple MyelomaMultiple MyelomaBelgium, France, Germany
-
Institut CurieActive, not recruitingNeuroblastoma | Opsoclonus Myoclonus SyndromeFrance, Austria, Italy, Spain, Sweden, Switzerland, United Kingdom
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National University of Ireland, Galway, IrelandJanssen Pharmaceuticals; Cancer Trials IrelandUnknownMultiple MyelomaIreland
-
Mayo ClinicCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedChronic Renal Failure With Uremic NephropathyFrance
-
European Myeloma NetworkJanssen, LPActive, not recruitingMultiple Myeloma | Extramedullary PlasmacytomaTurkey, Italy, Greece